EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutation spectrum of retinoblastoma patients in Vietnam

Dao Nguyen Ha Linh, Nguyen Van Huy, Phuoc-Dung Nguyen iD, Phuong Le Thi, Hoang Anh Tuan, Trong Van Nguyen, Thu Ha Tran, Hai Anh Tran, Thanh Dat Ta, Tuan L A Pham, The-Hung Bui, Thinh Huy Tran und 2 weitere

Molecular Genetics & Genomic Medicine · 2023

DOI: 10.1002/mgg3.2244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Dao Nguyen Ha Linh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vietnam Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retinoblastoma (RB), an intraocular malignancy commonly diagnosed in children, is mostly caused by inactivating mutations of both alleles of the RB1 gene. Early genetic screening for RB1 gene mutations would greatly improve treatment outcomes and patient management.

Methods

In this study, both somatic and germline mutations were detected in blood and tumour samples of 42 RB patients using direct sequencing and multiplex ligation‐dependent probe amplification.

Results

In total, 34 different mutations were found in 36 patients, including 1 SNP, 4 large deletions, 5 splicing sites, 1 missense, 7 frameshifts and 17 nonsense mutations. There were five novel mutations and one unreported which have not been found in large databases such as Leiden Open Variation Database (LOVD) and ClinVar.

Conclusion

A higher rate of RB patients carrying heterozygous germline mutation and highly prevalent with pathogenic truncated mutation, hence, early detection of RB is essential for vision salvation and genetic counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinal NeoplasmsChildHumansVietnamMutationGenetic Testing

Stichwörter der Autor:innen

MLPARB1 genemutationretinoblastomasequencing

Autor:innen und Institutionen

  • Hanoi Medical University, Hanoi, Vietnam.
  • National Institute of Ophthalmology, Hanoi, Vietnam.
  • Center for Molecular Medicine, Clinical Genetics Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Hanoi Medical University Hospital, Hanoi Medical University, Hanoi, Vietnam.

ORCID-Profile: Phuoc-Dung Nguyen, Van-Khanh Tran

Förderung

  • Vietnam Ministry of Health

Zitieren

APA

Linh, D. N. H., Van Huy, N., Nguyen, P. D., Le Thi, P., Tuan, H. A., Van Nguyen, T., Tran, T. H., Tran, H. A., Ta, T. D., Pham, T. L. A., Bui, T. H., Tran, T. H., Van Ta, T., & Tran, V. K. (2023). Mutation spectrum of retinoblastoma patients in Vietnam. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2244

Vancouver

Linh DNH, Van Huy N, Nguyen PD, Le Thi P, Tuan HA, Van Nguyen T, et al. Mutation spectrum of retinoblastoma patients in Vietnam. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2244

BibTeX
@article{Linh2023,
  author = {Linh, Dao Nguyen Ha and Van Huy, Nguyen and Nguyen, Phuoc-Dung and Le Thi, Phuong and Tuan, Hoang Anh and Van Nguyen, Trong and Tran, Thu Ha and Tran, Hai Anh and Ta, Thanh Dat and Pham, Tuan L A and Bui, The-Hung and Tran, Thinh Huy and Van Ta, Thanh and Tran, Van-Khanh},
  title = {Mutation spectrum of retinoblastoma patients in Vietnam},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  doi = {10.1002/mgg3.2244}
}
Kostenlos starten →